THE BUSINESS
The company makes transdermal wellness patches, a wearable alternative to pills, powders and gummies. The line covers eight consumer need-states — sleep, stress, pain and recovery, energy, focus, immunity and pre-workout — across 17 active SKUs in 28-day monthly packs, 8-count travel packs and multi-formula bundles. All products are manufactured in the United States in a GMP-certified facility, WERCSmart-registered and GS1-barcoded for big-box retail compliance.

FY2025 revenue was $813,811, up 3.1x from $263,855 in FY2023, with gross margin expanding from 21.0% to 68.2% over the same period. Approximately 97,000 units shipped across nine channels in FY2025. The business was built without outside capital.

WHAT A BUYER ACQUIRES
• Walmart shelf space that cannot be bought quickly — over 1,000 doors currently trading, roughly one Walmart store in five, plus Target and the Walmart marketplace. The compliance registrations, barcoding and retail-ready packaging behind that placement transfer with the business and apply directly to the next retailer.
• Nine operating channels: Walmart retail, Amazon, DTC storefront, TikTok Shop, iHerb, Walmart Marketplace, Target, wholesale and international.
• An eight-category portfolio rather than a single hero SKU, plus three developed formulations ready to commercialize.
• A capital-light operating model — outsourced GMP manufacturing, third-party fulfillment, no lease, no equipment. Vendor-financed inventory and a negative cash conversion cycle mean growth has been funded from operations.
• Full IP: trademarks, all formulations, packaging dielines, the product photo and video library, marketplace accounts and the customer email list.

GROWTH OPPORTUNITIES
Walmart door expansion: roughly 3,600 incremental doors remain available inside an account already won. New retail channels: the same compliance profile qualifies the line for drug, grocery and club retail. Subscription: monthly packs suit a subscription model that has never been built out. Paid acquisition: growth to date has used limited paid media. Product pipeline: three formulations await launch. International: effectively no presence.

OPERATIONS
Home-based, relocatable and semi-absentee capable, with manufacturing and fulfillment outsourced to established U.S. partners.

REASON FOR SELLING
This is the seller's fifth company; four previous businesses were started and successfully sold across 30 years in pharmaceutical and consumer products. The company has reached the point where growth depends on capital, paid media and retail relationships rather than founder effort — a different skill set from the one that took it from concept to national shelf placement.

Seller financing may be considered for a qualified buyer, and comprehensive transition support is included.

Cash flow is not disclosed publicly. Full financials, the earnings bridge, channel-level detail and supplier agreements are available to buyers who sign an NDA and complete BizBuySell's buyer profile.